Payer & Financing Models
By emphasizing quality over quantity, value-based reimbursement and risk-sharing models support patient-centered care while aiming to reduce total health care expenditures. Here you’ll find resources to keep you up to date on the latest in payer and financing concerns.
Managed Care & Value-Based Reimbursement – Madeline Shurtleff, PharmD
Prescribing Patterns For All Types Of Psychotropic Medications For Consumers With Schizophrenia Varied Across StatesArticleJune 20, 2022Prescribing patterns in the United States varied widely across the states for psychotropic medications prescribed to adult Medicaid beneficiaries diagnosed…
States Expand Access To Medicaid Behavioral Health ServicesArticleJanuary 17, 2022States are expanding access to Medicaid behavioral health services, mostly through funding from the 2021 American Rescue Plan Act (ARPA)…
10 Integration Models Reshaping Behavioral Health DeliveryDownloadable ResourceJanuary 18, 2022The types of integration models affect service lines, revenue, margins, and sustainability for providers and the patients they serve. Here…
Infographic – Racial & Ethnic Diversity In Clinical Trials: Overcoming Socioeconomic & Financial Barriers
CMS Extends Medicare Advantage Value-Based Insurance Design Model Through 2030ArticleApril 17, 2023
<strong>Going Hybrid—It’s The People</strong>ArticleApril 17, 2023
12% Of Adult Emergency Department Visits For A Behavioral Health IssueArticleApril 17, 2023
Don J Fowls, MD
Payer Section Advisor
Ask A Question About Payer & Financing Models
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
The Neuropsychiatric Inventory: Development & Applications
Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR
Distinguishing Sedation From Efficacy In Antipsychotic Treatment